Low-dose eribulin mesylate exerts antitumor effects in gastric cancer by inhibiting fibrosis via the suppression of epithelial–mesenchymal transition and acts synergistically with 5-fluorouracil

References

• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• ChenCYWuCWLoSSHsiehMCLuiWYShenKHPeritoneal carcinomatosis and lymph node metastasis are prognostic indicators in patients with Borrmann type IV gastric carcinomaHepatogastroenterology2002494587487712064011
   PubMedGoogle Scholar
• Japanese Gastric Cancer Association Registration CommitteeMaruyamaKKaminishiMGastric cancer treated in 1991 in Japan: data analysis of nationwide registryGastric Cancer200692516616767357
   PubMedGoogle Scholar
• SadeghiBArvieuxCGlehenOPeritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective studyCancer200088235836310640968
   PubMed Web of Science ®Google Scholar
• KoizumiWNaraharaHHaraTS-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trialLancet Oncol20089321522118282805
   PubMed Web of Science ®Google Scholar
• FushidaSKinoshitaJYagiYDual anti-cancer effects of weekly intraperitoneal docetaxel in treatment of advanced gastric cancer patients with peritoneal carcinomatosis: a feasibility and pharmacokinetic studyOncol Rep20081951305131018425392
   PubMed Web of Science ®Google Scholar
• ShiraoKBokuNYamadaYRandomized Phase III study of 5-fluorouracil continuous infusion vs. sequential methotrexate and 5-fluorouracil therapy in far advanced gastric cancer with peritoneal metastasis (JCOG0106)Jpn J Clin Oncol2013431097298024014884
   PubMed Web of Science ®Google Scholar
• FushidaSKinoshitaJKajiMPhase I/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosisCancer Chemother Pharmacol20137151265127223423490
   PubMed Web of Science ®Google Scholar
• YonemuraYKawamuraTNojimaNPostoperative results of left upper abdominal evisceration for advanced gastric cancerHepatogastroenterology2000473257157410791241
   PubMedGoogle Scholar
• OtsujiEKuriuYOkamotoKOutcome of surgical treatment for patients with scirrhous carcinoma of the stomachAm J Surg2004188332733215450843
   PubMed Web of Science ®Google Scholar
• YashiroMChungYSNishimuraSInoueTSowaMFibrosis in the peritoneum induced by scirrhous gastric cancer cells may act as “soil” for peritoneal disseminationCancer1996778 Suppl166816758608560
   PubMed Web of Science ®Google Scholar
• KalluriRZeisbergMFibroblasts in cancerNat Rev Cancer20066539240116572188
   PubMed Web of Science ®Google Scholar
• YashiroMChungYSSowaMRole of orthotopic fibroblasts in the development of scirrhous gastric carcinomaJpn J Cancer Res19948598838867961114
   PubMedGoogle Scholar
• SchorSLSchorAMGreyAMRushtonGFoetal and cancer patient fibroblasts produce an autocrine migration-stimulating factor not made by normal adult cellsJ Cell Sci198890Pt 33913993253289
   PubMedGoogle Scholar
• OlumiAFGrossfeldGDHaywardSWCarrollPRTistyTDCunhaGRCarcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epitheliumCancer Res199959195002501110519415
   PubMed Web of Science ®Google Scholar
• PintoMPBadtkeMMDudevoirMLHarrellJCJacobsenBMHorwitzKBVascular endothelial growth factor secreted by activated stroma enhances angiogenesis and hormone-independent growth of estrogen receptor-positive breast cancerCancer Res20107072655266420332242
   PubMed Web of Science ®Google Scholar
• TyanSWKuoWHHuangCKBreast cancer cells induce cancer-associated fibroblasts to secrete hepatocyte growth factor to enhance breast tumorigenesisPLoS One201161e1531321249190
   PubMed Web of Science ®Google Scholar
• FushidaSYonemuraYUranoTExpression of hepatocyte growth factor (HGF) and C-met gene in human gastric-cancer cell-linesInt J Oncol1993361067107021573474
   PubMed Web of Science ®Google Scholar
• ZiFHeJHeDLiYYangLCaiZFibroblast activation protein alpha in tumor microenvironment: recent progression and implications (review)Mol Med Rep20151153203321125593080
   PubMed Web of Science ®Google Scholar
• TsukadaTFushidaSHaradaSThe role of human peritoneal mesothelial cells in the fibrosis and progression of gastric cancerInt J Oncol201241247648222614335
   PubMed Web of Science ®Google Scholar
• HayEDAn overview of epithelio-mesenchymal transformationActa Anat (Basel)199515418208714286
   PubMedGoogle Scholar
• YangJWeinbergRAEpithelial-mesenchymal transition: at the crossroads of development and tumor metastasisDev Cell200814681882918539112
   PubMed Web of Science ®Google Scholar
• ThieryJPEpithelial-mesenchymal transitions in tumour progressionNat Rev Cancer20022644245412189386
   PubMed Web of Science ®Google Scholar
• UramotoHIwataTOnitsukaTShimokawaHHanagiriTOyamaTEpithelial-mesenchymal transition in EGFR-TKI acquired resistant lung adenocarcinomaAnticancer Res20103072513251720682976
   PubMed Web of Science ®Google Scholar
• NawshadALagambaDPoladAHayEDTransforming growth factor-beta signaling during epithelial-mesenchymal transformation: implications for embryogenesis and tumor metastasisCells Tissues Organs20051791–2112315942189
   PubMed Web of Science ®Google Scholar
• MaharaKKatoJTeruiTTransforming growth factor beta 1 secreted from scirrhous gastric cancer cells is associated with excess collagen deposition in the tissueBr J Cancer19946947777838142266
   PubMed Web of Science ®Google Scholar
• InoueTChungYSYashiroMTransforming growth factor-beta and hepatocyte growth factor produced by gastric fibroblasts stimulate the invasiveness of scirrhous gastric cancer cellsJpn J Cancer Res19978821521599119743
   PubMedGoogle Scholar
• SaitoHFushidaSHaradaSImportance of human peritoneal mesothelial cells in the progression, fibrosis, and control of gastric cancer: inhibition of growth and fibrosis by tranilastGastric Cancer2018211556728540637
   PubMed Web of Science ®Google Scholar
• TowleMJSalvatoKABudrowJIn vitro and in vivo anticancer activities of synthetic macrocyclic ketone analogues of halichondrin BCancer Res20016131013102111221827
   PubMed Web of Science ®Google Scholar
• JordanMAKamathKMannaTThe primary antimitotic mechanism of action of the synthetic halichondrin E7389 is suppression of microtubule growthMol Cancer Ther2005471086109516020666
   PubMed Web of Science ®Google Scholar
• SchoffskiPChawlaSMakiRGEribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trialLancet2016387100281629163726874885
   PubMed Web of Science ®Google Scholar
• CortesJO’ShaughnessyJLoeschDEribulin monotherapy versus treatment of physician’s choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised studyLancet2011377976991492321376385
   PubMed Web of Science ®Google Scholar
• KaufmanPAAwadaATwelvesCPhase III open-label randomized study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline and a taxaneJ Clin Oncol201533659460125605862
   PubMed Web of Science ®Google Scholar
• YoshidaTOzawaYKimuraTEribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) statesBr J Cancer201411061497150524569463
   PubMed Web of Science ®Google Scholar
• YungSLiFKChanTMPeritoneal mesothelial cell culture and biologyPerit Dial Int200626216217316623418
   PubMed Web of Science ®Google Scholar
• MotoyamaTHojoHWatanabeHComparison of seven cell lines derived from human gastric carcinomasActa Pathol Jpn198636165833962675
   PubMedGoogle Scholar
• NakataniHTaharaEYoshidaTDetection of amplified DNA sequences in gastric cancers by a DNA renaturation method in gelJpn J Cancer Res19867798498533095279
   PubMedGoogle Scholar
• YashiroMChungYSNishimuraSInoueTSowaMEstablishment of two new schirrhous gastric cancer cell lines: analysis of factors associated with disseminated metastasisBr J Cancer1995725120012107577468
   PubMed Web of Science ®Google Scholar
• ChouTCTalalayPQuantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitorsAdv Enzyme Regul19842227556382953
   PubMedGoogle Scholar
• ZeisbergEMPotentaSXieLZeisbergMLalluriRDiscovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblastsCancer Res20076721101231012817974953
   PubMed Web of Science ®Google Scholar
• YashiroMChungYSNishimuraSInoueTSowaMPeritoneal metastatic model for human scirrhous gastric carcinoma in nude miceClin Exp Metastasis199614143548521616
   PubMed Web of Science ®Google Scholar
• KoyamaTYashiroMInoueTNishimuraSHirakawa-YS ChungKTGF-beta1 secreted by gastric fibroblasts up-regulates CD44H expression and stimulates the peritoneal metastatic ability of scirrhous gastric cancer cellsInt J Oncol200016235536210639581
   PubMed Web of Science ®Google Scholar
• NishimuraSChungYSYashiroMInoueTSowaMRole of alpha 2 beta 1- and alpha 3 beta 1-integrin in the peritoneal implantation of scirrhous gastric carcinomaBr J Cancer1996749140614128912536
   PubMed Web of Science ®Google Scholar
• OkazakiMFushidaSHaradaSThe angiotensin II type 1 receptor blocker candesartan suppresses proliferation and fibrosis in gastric cancerCancer Lett20143551465325224569
   PubMed Web of Science ®Google Scholar
• ShinboTFushidaSTsukadaTProtein-bound polysaccharide K suppresses tumor fibrosis in gastric cancer by inhibiting the TGF-β signaling pathwayOncol Rep201533255355825435013
   PubMed Web of Science ®Google Scholar
• TsukadaTFushidaSHaradaSLow-dose paclitaxel modulates tumour fibrosis in gastric cancerInt J Oncol20134241167117423443842
   PubMed Web of Science ®Google Scholar
• DongCLiZAlvarezRJrFengXHGoldschmidt-ClermontPJMicrotubule binding to Smads may regulate TGF-beta activityMol Cell200051273410678166
   PubMed Web of Science ®Google Scholar
• NogalesEWolfSGKhanIALuduenaRFDowningKAStructure of tubulin at 6.5 A and location of the taxol-binding siteNature199537565304244277760939
   PubMed Web of Science ®Google Scholar
• SmithJAWilsonLAzarenkoOEribulin binds at microtubule ends to a single site on tubulin to suppress dynamic instabilityBiochemistry20104961331133720030375
   PubMed Web of Science ®Google Scholar
• SinghASettlemanJEMT cancer stem cells and drug resistance: an emerging axis of evil in the war on cancerOncogene201029344741475120531305
   PubMed Web of Science ®Google Scholar
• ThomsonSBuckEPettiFEpithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibitionCancer Res200565209455946216230409
   PubMed Web of Science ®Google Scholar
• ZhuoWWangYZhuoXZhangYAoXChenZKnockdown of Snail, a novel zinc finger transcription factor, via RNA interference increases A549 cell sensitivity to cisplatin via JNK/mitochondrial pathwayLung Cancer200862181418372076
   PubMed Web of Science ®Google Scholar
• ArumugamTRamachandranVFournierKFEpithelial to mesenchymal transition contributes to drug resistance in pancreatic cancerCancer Res200969145820582819584296
   PubMed Web of Science ®Google Scholar
• WangZLiYKongDAcquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathwayCancer Res20096962400240719276344
   PubMed Web of Science ®Google Scholar
• TerashimaMSakaiKTogashiYSynergistic antitumor effects of S-1 with eribulin in vitro and in vivo for triple-negative breast cancer cell linesSpringerplus2014341725140293
   PubMed Web of Science ®Google Scholar
• FunahashiYOkamotoKAdachiYEribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer modelsCancer Sci2014105101334134225060424
   PubMed Web of Science ®Google Scholar
• KawanoSAsanoMAdachiYMatsuiJAntimitotic and non-mitotic effects of eribulin mesilate in soft tissue sarcomaAnticancer Res20163641553156127069131
   PubMed Web of Science ®Google Scholar
• SchwartzELAntivascular actions of microtubule-binding drugsClin Cancer Res20091582594260119351751
   PubMed Web of Science ®Google Scholar
• GrantDSWilliamsTLZahaczewskyMDickerAPComparison of antiangiogenic activities using paclitaxel (taxol) and docetaxel (taxotere)Int J Cancer2003104112112912532428
   PubMed Web of Science ®Google Scholar
• LiuHLLiuDDingGRLiaoPFZhangJWHypoxia-inducible factor-1α and Wnt/β-catenin signaling pathways promote the invasion of hypoxic gastric cancer cellsMol Med Rep20151233365337325997455
   PubMed Web of Science ®Google Scholar